Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Edward John Allera
Legal Innovators Interview Series
United States: Legal Innovators Interview Series - The General Counsel At Covis Pharma Discusses The World Of Pharmaceutical Approvals Around The Globe - Corporate Counsel (Podcast) 12 May 2021 by Edward John Allera and Matthew L. Fedowitz Buchanan Ingersoll & Rooney PC Your LinkedIn Connections with the authors To print this article, all you need is to be registered or login on Mondaq.com.
Life Sciences Executive Exchange Series
United States: Life Sciences Executive Exchange Series - Webinar Recap 01 April 2021 by Barbara A. Binzak Blumenfeld and Edward John Allera Buchanan Ingersoll & Rooney PC Your LinkedIn Connections with the authors To print this article, all you need is to be registered or login on Mondaq.com. In this series, designed for experienced pharma professionals and executives, Buchanan professionals will tackle critical issues to help you navigate the Pharma Product Lifecycle.
Operating At Warp Speed: Key Takeaways From COVID-19 Clinical Trials
To print this article, all you need is to be registered or login on Mondaq.com. As we enter the latest wave of the novel coronavirus attack, we are only nine months into a public health war that is proving difficult and lengthy. In the first few months, the fog of war required split-second decisions about novel and critical issues with limited data available.
Leaders In Life Sciences Key Takeaways
Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice): Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below. Mondaq has a "free to view" business model.
Key Business And IP Considerations For Furthering Drug Repurposing Programs
Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice): Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below. Mondaq has a "free to view" business model.
Life Sciences Playbook - Navigating Operational And Regulatory Challenges While Emerging From The COVID-19 Pandemic - Food, Drugs, Healthcare, Life Sciences - United States
Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice): Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below. Mondaq has a "free to view" business model.
Top 10 Investor Insights On Life Sciences Post-COVID-19
Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice): Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below. Mondaq has a "free to view" business model.
Increasing Revenue And Decreasing Costs As Life Sciences Companies Emerge From COVID-19
Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice): Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below. Mondaq has a "free to view" business model.
Make Your Voice Heard In Washington Amid The COVID-19 Pandemic
Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice): Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below. Mondaq has a "free to view" business model.
Html.Raw(In The Chaos Of COVID-19 Pandemic, What Is "Current" In cGMP? - Food, Drugs, Healthcare, Life Sciences - United States)
Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice): Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below. Mondaq has a "free to view" business model.
FDA's Coronavirus Triage - How Pharma Can Work With The Agency To Tackle A Pandemic - Food, Drugs, Healthcare, Life Sciences - United States
To print this article, all you need is to be registered or login on Mondaq.com. The world is facing a health crisis at a level it has not experienced in generations. The U.S. and countries worldwide are grappling with how to best protect citizens in the wake of the transmission of the SARS-CoV-2 virus and the resulting coronavirus disease 2019 (COVID-19) pandemic. Throughout its history, the U.S. Food and Drug Administration (FDA) has always been responsive to public health demands.
Clinical Trial Data In The Time Of COVID-19
Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice): Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below. Mondaq has a "free to view" business model.
The Changing World Of New Drug Applications And How To Successfully Play In The Middle Ground
Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice): Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below. Mondaq has a "free to view" business model.
From White Oak with Love An Attendee’s Perspective of the Reagan-Udall Foundation for the FDA Annual Meeting | JD Supra
Updated: May 25, 2018: JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations.
A Practical Approach for Resolving the Pediatric Oncology Drug Labeling Crisis
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Already signed up? Log in here By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
FDA Reaffirms Its Commitment to the Approval of Stem Cell Therapies Amidst Enforcement Actions Against “Unscrupulous Actors”
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Already signed up? Log in here By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Edward John
Contact Edward John, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack